BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Onyx Pharmaceuticals, Inc. (ONXX) Announces N. Anthony Coles, M.D. Elected Chairman of Its Board of Directors


12/17/2012 10:04:25 AM

SAN FRANCISCO, CA--(Marketwire - December 17, 2012) - Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that its Board of Directors has elected N. Anthony Coles, M.D., Chairman of the Board. Dr. Coles is currently President, Chief Executive Officer and a member of Onyx's Board. Paul Goddard, Ph.D., will continue to serve as Lead Independent Director of the Onyx Board.

"On behalf of the Board of Directors, I would like to congratulate Tony on this well-deserved appointment," said Dr. Goddard. "Through his steadfast, focused leadership, Onyx has grown exponentially, transforming from a company with one therapy to a diversified biopharmaceutical leader with three approved treatments to address some of the most difficult-to-treat cancers."

"Paul's leadership has been instrumental in our ability to realize Onyx's growth and transformation," said Dr. Coles. "I look forward to continuing our successful partnership as Onyx moves into this next stage as a global, multi-product company."

About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->